Allworth Financial’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.24K | Buy |
610
+238
| +64% | +$1.26K | ﹤0.01% | 3486 |
|
2025
Q1 | $2.74K | Sell |
372
-25
| -6% | -$184 | ﹤0.01% | 3066 |
|
2024
Q4 | $4.88K | Buy |
397
+382
| +2,547% | +$4.69K | ﹤0.01% | 2771 |
|
2024
Q3 | $411 | Hold |
15
| – | – | ﹤0.01% | 3461 |
|
2024
Q2 | $390 | Hold |
15
| – | – | ﹤0.01% | 3435 |
|
2024
Q1 | $320 | Hold |
15
| – | – | ﹤0.01% | 3384 |
|
2023
Q4 | $288 | Sell |
15
-38
| -72% | -$730 | ﹤0.01% | 3244 |
|
2023
Q3 | $851 | Buy |
+53
| New | +$851 | ﹤0.01% | 2899 |
|
2022
Q2 | – | Sell |
-9
| Closed | – | – | 2652 |
|
2022
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 2278 |
|
2015
Q4 | – | Sell |
-286
| Closed | -$11K | – | 645 |
|
2015
Q3 | $11K | Hold |
286
| – | – | ﹤0.01% | 381 |
|
2015
Q2 | $10K | Hold |
286
| – | – | ﹤0.01% | 386 |
|
2015
Q1 | $10K | Buy |
+286
| New | +$10K | ﹤0.01% | 397 |
|